Adult Mouse Digit Amputation and Regeneration: A Simple Model to Investigate Mammalian Blastema Formation and Intramembranous Ossification
July 12th, 2019
9K views
Here, we present a protocol of adult mouse terminal phalanx amputation to investigate mammalian blastema formation and intramembranous ossification, analyzed by fluorescent immunohistochemistry and sequential in-vivo microcomputed tomography.
Overview
This article presents a protocol for adult mouse terminal phalanx amputation to study mammalian blastema formation and intramembranous ossification. The investigation utilizes fluorescent immunohistochemistry and in-vivo microcomputed tomography to analyze the regeneration process.
Key Study Components
Area of Science
- Neuroscience
- Regenerative Medicine
- Bone Biology
Background
- The P3 amputation model is a preclinical tool for studying mammalian epimorphic regeneration.
- This model helps identify critical cell populations involved in regeneration.
- It allows for the study of revascularization and ossification processes.
- The procedure does not require complex bone stabilization devices.
Purpose of Study
- To investigate the mechanisms controlling endogenous regeneration in mammals.
- To analyze early and late blastemal cell populations during regeneration.
- To explore the processes of intramembranous ossification.
Methods Used
- Adult CD-1 mice were used for the amputation procedure.
- Fluorescent immunohistochemistry was employed for analysis.
- In-vivo microcomputed tomography was utilized to visualize regeneration.
- Topical anesthetics were applied to minimize discomfort during surgery.
Main Results
- The protocol successfully demonstrated the surgical procedure for phalanx amputation.
- Key cell populations involved in regeneration were identified.
- Revascularization and ossification processes were effectively analyzed.
- The study provides insights into mammalian regenerative mechanisms.
Conclusions
- The P3 amputation model is a valuable tool for studying regeneration.
- Fluorescent immunohistochemistry and microcomputed tomography are effective methods for analysis.
- This research enhances understanding of mammalian blastema formation and ossification.
Frequently Asked Questions
What is the P3 amputation model?
The P3 amputation model is a preclinical model used to study mammalian epimorphic regeneration.
What techniques are used in this study?
Fluorescent immunohistochemistry and in-vivo microcomputed tomography are the primary techniques used.
What are the main findings of the study?
The study identifies critical cell populations and analyzes revascularization and ossification during regeneration.
How does this research contribute to regenerative medicine?
It provides insights into the mechanisms of mammalian regeneration, which can inform future therapies.
What is the significance of intramembranous ossification?
Intramembranous ossification is a key process in bone formation and regeneration, crucial for understanding healing mechanisms.
Who conducted the study?
The study was conducted by a team from the laboratory including Osama Qureshi, Alyssa Falck, Katherine Zimmel, and Regina Brunaeur.
Executive Industry Relevance
The adult mouse P3 amputation model provides a preclinical system to investigate mammalian epimorphic regeneration, offering insights into blastema formation and intramembranous ossification. This model supports target validation by enabling the identification of critical cell populations and mechanisms controlling endogenous regeneration. It facilitates mechanistic de-risking in regenerative medicine by allowing quantitative analysis of bone volume and length changes via sequential in vivo micro-CT and fluorescence immunohistochemistry.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by identifying early-and-late blastema cell populations involved in regeneration.
- Operational Value: Supports biological de-risking through reproducible amputation procedures and standardized tissue processing for immunohistochemistry.
- Predictive Value: Facilitates target confidence by linking blastema formation to successful regenerative outcomes versus fibrotic healing in proximal amputations.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for studying revascularization in the context of regeneration using fluorescent antibody labeling.
- Operational Value: Enables assay standardization through consistent P3 amputation planes confirmed by micro-CT imaging.
- Predictive Value: Provides quantitative outputs such as bone volume (mm³) and length measurements to support reliable compound evaluation in regeneration assays.
Translational & Preclinical Research
- Scientific Value: Investigates intramembranous ossification without complex bone stabilization, enabling analysis of natural healing processes.
- Operational Value: Offers disease-relevant system continuity from discovery through preclinical validation via longitudinal micro-CT scanning.
- Predictive Value: Supports risk-adjusted advancement decisions by distinguishing regenerative success (distal amputation) from failure (proximal amputation leading to fibrosis).
Pipeline & Workflow Integration
The P3 amputation model integrates into the discovery continuum from target identification through preclinical validation, supporting hypothesis testing and mechanistic analysis of regeneration pathways.
- Discovery Biology: Supports hypothesis testing by enabling the study of revascularization and blastema formation in a mammalian epimorphic regeneration model.
- Screening: Describes assay readiness through reproducible tissue fixation, sectioning, and immunostaining protocols for consistent biomarker detection.
- Analytics: Highlights quantitative measurements of bone volume and length changes via micro-CT and ImageJ/BoneJ analysis to compare regenerative conditions.
- Translational Research: Connects to preclinical continuity by modeling intramembranous ossification as a key process in skeletal regeneration.
- Enterprise Reuse: Frames the method as a reusable platform for testing pro-regenerative compounds or genetic modifications across multiple experimental endpoints.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through mechanistic insight into blastema-mediated regeneration.
- Operational Value: Standardization and reproducibility via defined amputation planes, histological processing, and imaging protocols.
- Strategic Value: Better go/no-go decisions by distinguishing regenerative from fibrotic healing outcomes.
- Portfolio Impact: Risk-adjusted prioritization of regeneration strategies based on quantitative bone restoration metrics.
Implementation Considerations
- Required scientific expertise in microsurgery, histology, and micro-CT imaging.
- Instrumentation needs include dissection microscopes, microtomes, staining jars, slide warmers, and micro-CT scanners with specific voxel settings.
- Cross-team standardization requires consistent amputation techniques, anesthesia protocols, and tissue fixation timelines.
- Adaptation considerations across model systems involve verifying distal versus proximal amputation outcomes in different mouse strains or ages.
- Practical limitations include the restriction of regeneration to distal P3 amputations, with proximal cuts leading to scarring rather than blastema formation.
Biopharma FAQs
Why does blastema formation matter for target validation in regeneration?
Blastema formation is a key indicator of successful epimorphic regeneration in the P3 amputation model, distinguishing regenerative healing from fibrotic scoring. Its presence correlates with restored skeletal length via intramembranous ossification. Quantifying blastema cell populations supports target validation by linking specific cell types to regenerative outcomes.
How does isolating the independent variable of amputation level fit the discovery pipeline?
Isolating amputation level (distal vs. proximal P3) as an independent variable enables clear comparison between regenerative and non-regenerative outcomes. This experimental control supports hypothesis testing in early discovery by identifying conditions that permit blastema formation. It fits the discovery pipeline by providing a reproducible model to test genetic or pharmacological modifiers of regeneration.
What quantitative dependent variable measurements enable assessment of regeneration?
Dependent variables such as bone volume (mm³) and bone length, measured via sequential in vivo micro-CT and ImageJ analysis, enable quantitative assessment of regeneration. These metrics track morphological changes over time, allowing comparison of regenerative efficacy across conditions. They provide objective, numerical endpoints for evaluating pro-regenerative interventions.
Why do replication requirements matter for cross-functional collaboration in regeneration studies?
Replication requirements ensure consistent P3 amputation planes and histological processing, which are critical for reproducible blastema and ossification analysis across teams. Standardized protocols allow histology, imaging, and data analysis teams to compare results reliably. This consistency supports cross-functional collaboration in target validation and lead identification efforts.
What statistical analysis capabilities are required before implementing the P3 model in screening?
Before implementation, teams require statistical capabilities to analyze longitudinal bone volume and length changes across time points and experimental groups. This includes comparing regeneration metrics between distal (regenerative) and proximal (fibrotic) amputation conditions. Such analysis enables data-driven go/no-go decisions in preclinical screening of regeneration-promoting strategies.
Chapters in this video
0:04
Title
0:47
Adult Mouse Hind Limb Distal P3 Amputation
2:01
Digit Collection and Tissue Preparation
2:47
Immunostaining for Blastema Formation and Intramembranous Ossification
4:30
Sequential In Vivo Microcomputed Tomography (microCT) Imaging
5:50
Reconstructed Bone Image Analysis
8:15
Results: Representative Regenerative Bone Analyses
8:47
Conclusion
